Atrial Fibrillation

AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain management. AtriCure’s cryoICE is the first U.S. Food and Drug Administration (FDA)-cleared c...

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with...

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that continuous cardiac monitoring with the Reveal XT in...

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to correct a leaky mitral valve had fewer...
cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy
AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain...
CTSN, atrial fibrillation, surgical ablation, mitral valve surgery
New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the...
Boston Scientific, Watchman LAA device, FDA approval
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman...
cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy
The cryoICE cryo ablation probe (CRYO2) from AtriCure Inc. is designed to provide cryoanalgesia for temporary pain management. It is the
The Watchman left atrial appendage closure device from Boston Scientific Corp. is a catheter-delivered heart implant designed to close the...
The CAAS A-Valve from Pie Medical Imaging BV is the first 510(k)-cleared image analysis technology to determine aortic regurgitation based...

Articles

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to correct a leaky mitral valve had fewer...
cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy
AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain...
Boston Scientific, Watchman LAA device, FDA approval
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman...
atrial fibrillation, women, seniors, guidelines, blood thinners, DCRI
Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis...

Video Center

The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
8 hours 51 min ago
It’s been no secret that the American healthcare system needed to change to survive economically...
6 weeks 12 hours ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
8 weeks 15 hours ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available